Thomas Edward Schoenherr, CEO, Diagnostics at Tempus AI, Inc. (TEM), sold 17,314 shares at $49.61 ($930K) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Scheduled sale ($930k) by CEO, Diagnostics under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.61 | 9,232 | $458K | 49.2% |
| 2 | $55.97 | 3,094 | $173K | 18.6% |
| 3 | $56.47 | 100 | $6K | 0.6% |
| 4 | $57.94 | 500 | $29K | 3.1% |
| 5 | $59.97 | 2,994 | $180K | 19.3% |
| 6 | $60.45 | 900 |
| $54K |
| 5.9% |
| 7 | $61.23 | 494 | $30K | 3.3% |
| Total | $53.71 avg | 17,314 | $930K | 100% |
| Filing → |
| TEM | SELL | 2026-05-21 | $70K | — | Filing → |